SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
2025 · Nature · 49 citations
https://doi.org/10.1038/s41586-025-09655-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
49
Citations
1
h-index
1
i10-index
Gabriel Alatrash is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & COVID-19 and healthcare impacts & Immunotherapy and Immune Responses. The author has an h-index of 1, co-authored 4 publications.
Click to start Chat